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The finite range of a proton beam or heavier charged particle 
beam can be a double-edged sword. While it is the biggest 
physical/dosimetric advantage of particle beam therapy, the 
range over- or undershoot typically requires extra margins 
that can compromise the conformality of the dose 
distributions substantially. Recent developments aim at 
imaging the range of the particle beam in the patient, to (1) 
verify the range, and (2) potentially correct for any range 
discrepancies. We will review the state of the art of imaging 
for range assessment, focusing in particular on prompt 
gamma imaging.  
Significant progress has recently been made in the field of 
prompt gamma imaging.  Range errors of 1 mm are 
detectable in phantoms. Spectroscopic methods potentially 
allow one to obtain information about the elemental 
composition of the tissue. Commercial systems are under 
development and have recently been tested in the clinic. In 
addition to systems consisting of a detector-collimator 
combination, Compton cameras are under development for 
the 3D reconstruction of the prompt gamma sources. Prompt 
gamma imaging competes with other range imaging 
techniques such as PET imaging of oxygen-15 and carbon-11, 
and MRI imaging of the biological changes resulting from 
irradiating tissues. Another recent development is thermo-
acoustic imaging, utilizing the ultrasound signal that a high 
intensity particle beam produces in tissue due to quick 
thermal expansion. 
Once the particle range in the patient can be measured (a) in 
the patient,  (b) in realtime, (c) with millimeter accuracy, 
the range margins can be reduced, resulting in significant 
improvements of treatment quality for many disease sites. 
Unfortunately, none of the techniques developed so far fulfill 
all criteria (a,b,c) above. Millimeter accuracy is sometimes 
achievable but not in patients or not in all patients. Realtime 
measurement and control is only feasible with prompt 
gamma and thermo-acoustic imaging. Of the techniques 
currently under development, it appears that prompt gamma 
imaging has the best chance of fulfilling all the criteria above 
and becoming a valuable tool for particle range control in the 
clinic in the near future.  
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Aim: Protontherapy provided many evidences on the quality 
and accuracy in planning a treatment. Pencil-beam scanning 
technology with protons enables clinicians to precisely 
manipulate and direct the beam so that its energy conforms 
exactly to the unique size and shape of the tumor. This 
technique shows remarkable advantages in conforming the 
dose to the target.  
However, the main issue for many years has been the non-
accessible technology behind it. The huge expenses 
compared with conventional radiation therapy remain costs 
issues. 
Lowering costs providing a new solution for proton therapy 
facilities with active scanning technique is opening a new 
perspective in this field, allowing a larger use of proton 
beams. 
One of constraints that can drastically lower the costs is the 
use of a fixed source and not a grantry.  
Methods: The scope of this study is providing a full 
investigation from the positioning to the dose delivery to the 
patient, using an alternative position in system that 
reproduce configurations gantry-couch like, and propose 
additional not-standard configurations that help a better 
planning. 
A robot arm handling a couch offers an automated movement 
of the patient around the nozzle, providing more freedom 
and compensating the lack of gantry. The positioning system 
is controlled and interfaced with a dedicated software 
translating and converting complex motions to equivalent 
once in more standard positioning. 
Results: Full Monte Carlo investigations for plan with 
different setting are realized to check configurations of 
Nozzle-Robotic system and their impact on the treatment 
planning. It is possible then to see when we get advantages in 
combining such solutions. This is reached once we have a 
system well integrated within the the full workflow and the 
planning system. 
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Purpose: In medical applications, about 20 MeV and 100 μA 
proton beams are used for the production of PET 
radioisotopes. In hadrontherapy, energies of hundreds MeV 
per nucleon and intensities below 1 nA are employed. To 
monitor beams in this wide range of intensities with a single 
detector, the Universal BEam Monitoring detector (UniBEaM) 
based on doped silica and optical fibres was designed, built 
and tested. 
Materials and methods: The UniBEaM detector is based on a 
single doped silica fibre moved through the beam. The 
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collected light signal provides information on the beam 
profile. A first prototype was developed and tested with 2 
MeV protons [1]. On this basis, a fully motorized device was 
designed and built for the Bern medical cyclotron [2], which 
is used for the production of PET radioisotopes and multi-
disciplinary research activities. The 10 cm long and 400 μm 
diameter sensing fiber is connected with a commercial 
optical fiber transporting the signal outside of the bunker. 
Cerium, antimony doped and non-doped sensing silica fibres 
were used, according to the intensity range. The fibres 
operate in vacuum and the signal is read out by a photo diode 
or by a PMT. The read out device, the control of the motor 
and the DAQ are integrated into a single compact apparatus. 
Results: The UniBEaM detector was tested at the Bern 
medical cyclotron delivering beams from a few pA to 150 μA 
[3]. Two beam profiles are reported in Figure 1, taken at 50 
pA and 1 μA, respectively. Due to their higher light yield, Ce 
doped fibres were used for intensities in the pico- and 
nanoampere range. Here the signal is recorded at successive 
steady positions of the fibre by single photon counting. For 
intensities from 100 nA to 1 μA, Sb doped fibres read out by a 
photodiode were used. The fiber is now moved continuously 
and the amplitude of the signal recorded. From 1 nA to 1 μA, 
the output signal was found to be linear with respect to the 
beam intensity. In this range, the position of the beam can 
be measured with a precision of about 0.1 mm, allowing the 
use of the UniBEaM detector for beam dynamics studies [4]. 
At intensities above 1 μA, a non-doped sensing fibre was 
used. Due to the dependence of the light transmission on 
temperature, the beam profile was found to be distorted, 
with a consequent non-linearity of the signal with respect to 
intensity. Nevertheless, the position of the beam can be 
monitored. This is a key feature for radioisotope production, 
especially if a solid target is used. 
Conclusions: The UniBEaM detector is based on the collection 
of the optical signal produced by an ion beam traversing a 
silica fiber. This device was successfully tested at the Bern 
medical cyclotron at intensities ranging from a few pA to 
about 20 μA, opening the way for its use in the production of 
medical radioisotopes and cancer hadrontherapy. Its 
commercialization is underway. 
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Figure 1 – Beam profiles measured at 50 pA (left) and 1 A 
(right). 
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Microbeam Radiation Therapy (MRT) is a novel technique[1]  
using spatially fractionated, intense, highly collimated, 
parallel arrays of X-ray beams generated at 3rd generation 
synchrotron facilities like the ESRF in Grenoble, France. The 
insertion of an adequate multislit collimator[2] produces 
microbeams with a FWHM between 20 and 100 μm with 
separations between 100 and 400 μm to be delivered at an 
extremely high dose rate (up to 20kGy/sec) to best exploit 
the dose volume effect with peak entrance dose values well 
above several hundreds of Gy, demonstrating a very high 
normal tissue tolerance even for the immature tissue [3]. The 
differential effects[4] between normal tissue vasculature and 
tumor vascular networks promote this novel approach and 
questions one of the dogmas in radiation therapy: namely, 
that radiation therapy is aiming at a dose distributions with 
the primary goal to maximize the dose at the target, while 
minimizing the dose to the normal tissue in order to generally 
optimize the treatment in cancer therapy. An overview of 
the most important findings in radiation biology as well as 
achievements in Medical Physics will be summarized 
reflecting the current status of the project. 
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Purpose: Therapeutic irradiation of brain cancers is 
associated with severe cognitive deficits in patients who 
survive long enough after irradiation. Radiotherapy-induced 
brain damage and dementia are associated to deficits in 
hippocampal-dependent mechanisms of learning and memory 
[1]. In preclinical rodent models, synchrotron-generated 
arrays of microbeams have shown unprecedented therapeutic 
effect on aggressive tumors of the central nervous system; 
furthermore microbeams are very well tolerated by normal 
tissues [2,3]. This latter effect is due to a minimal dose 
spreading outside the microbeam path. Recently, we showed 
that irradiation of the sensorimotor cortex of epileptic rats 
with synchrotron-generated microbeams reduces seizures 
without disrupting neurological functions [4]. Here we 
explored the long-term effects of microbeam versus 
broadbeam irradiation on hippocampal neurogenesis.  
Materials/Methods: Two groups of male Wistar rats (175-200 
g, two months of age) were irradiated with 5 or 10 Gy 
broadbeams, 3 groups were irradiated with 9 parallel 
microbeam arrays (75 μm wide, spaced 200 μm center-to-
center; peak entrance dose: 150, 300 or 600 Gy). The control 
group was not irradiated. Eight months later, we assessed 
cognitive functions by the Morris water maze, depressive-like 
